Selected research
Market Outlook & Growth Opportunities
Global Radiochemistry PET Cyclotron Market Outlook and Growth Opportunities 2026
Market perspective
The global Radiochemistry PET Cyclotron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Radiochemistry PET Cyclotron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radiochemistry PET Cyclotron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radiochemistry PET Cyclotron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Radiochemistry PET Cyclotron market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Radiochemistry PET Cyclotron market include IBA Radiopharma Solutions, Siemens Healthineers, GE Healthcare, Advanced Cyclotron Systems (ACSI), Sumitomo Heavy Industries, Best Cyclotron Systems, Ionetix Corporation and isoSolution, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Radiochemistry PET Cyclotron market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radiochemistry PET Cyclotron and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radiochemistry PET Cyclotron sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiochemistry PET Cyclotron market size, projected growth trends, production technologies, key applications, and end-use industries.
Radiochemistry PET Cyclotron Segment by Company
IBA Radiopharma Solutions
Siemens Healthineers
GE Healthcare
Advanced Cyclotron Systems (ACSI)
Sumitomo Heavy Industries
Best Cyclotron Systems
Ionetix Corporation
isoSolution
Radiochemistry PET Cyclotron Segment by Type
Low-Energy Cyclotrons
Medium-Energy Cyclotrons
High-Energy Cyclotrons
Radiochemistry PET Cyclotron Segment by Application
Pharmaceutical Industry
Hospital
Research & Academics
Radiochemistry PET Cyclotron Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Radiochemistry PET Cyclotron status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Radiochemistry PET Cyclotron market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Radiochemistry PET Cyclotron significant trends, drivers, influence factors in global and regions.
6. To analyze Radiochemistry PET Cyclotron competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiochemistry PET Cyclotron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiochemistry PET Cyclotron and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiochemistry PET Cyclotron.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiochemistry PET Cyclotron market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiochemistry PET Cyclotron industry.
Chapter 3: Detailed analysis of Radiochemistry PET Cyclotron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Radiochemistry PET Cyclotron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Radiochemistry PET Cyclotron in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Low-Energy Cyclotrons
- Medium-Energy Cyclotrons
- High-Energy Cyclotrons
Applications
- Pharmaceutical Industry
- Hospital
- Research & Academics
Companies covered
- IBA Radiopharma Solutions
- Siemens Healthineers
- GE Healthcare
- Advanced Cyclotron Systems (ACSI)
- Sumitomo Heavy Industries
- Best Cyclotron Systems
- Ionetix Corporation
- isoSolution
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 1.2.2 Global Radiochemistry PET Cyclotron Sales Volume (2021-2032)
- 1.2.3 Global Radiochemistry PET Cyclotron Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Radiochemistry PET Cyclotron Market Dynamics
- 2.1 Radiochemistry PET Cyclotron Industry Trends
- 2.2 Radiochemistry PET Cyclotron Industry Drivers
- 2.3 Radiochemistry PET Cyclotron Industry Opportunities and Challenges
- 2.4 Radiochemistry PET Cyclotron Industry Restraints
3 Radiochemistry PET Cyclotron Market by Company
- 3.1 Global Radiochemistry PET Cyclotron Company Revenue Ranking in 2025
- 3.2 Global Radiochemistry PET Cyclotron Revenue by Company (2021-2026)
- 3.3 Global Radiochemistry PET Cyclotron Sales Volume by Company (2021-2026)
- 3.4 Global Radiochemistry PET Cyclotron Average Price by Company (2021-2026)
- 3.5 Global Radiochemistry PET Cyclotron Company Ranking (2024-2026)
- 3.6 Global Radiochemistry PET Cyclotron Company Manufacturing Base and Headquarters
- 3.7 Global Radiochemistry PET Cyclotron Company Product Type and Application
- 3.8 Global Radiochemistry PET Cyclotron Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Radiochemistry PET Cyclotron Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Radiochemistry PET Cyclotron Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Radiochemistry PET Cyclotron Market by Type
- 4.1 Radiochemistry PET Cyclotron Type Introduction
- 4.1.1 Low-Energy Cyclotrons
- 4.1.2 Medium-Energy Cyclotrons
- 4.1.3 High-Energy Cyclotrons
- 4.2 Global Radiochemistry PET Cyclotron Sales Volume by Type
- 4.2.1 Global Radiochemistry PET Cyclotron Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radiochemistry PET Cyclotron Sales Volume by Type (2021-2032)
- 4.2.3 Global Radiochemistry PET Cyclotron Sales Volume Share by Type (2021-2032)
- 4.3 Global Radiochemistry PET Cyclotron Sales Value by Type
- 4.3.1 Global Radiochemistry PET Cyclotron Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radiochemistry PET Cyclotron Sales Value by Type (2021-2032)
- 4.3.3 Global Radiochemistry PET Cyclotron Sales Value Share by Type (2021-2032)
5 Radiochemistry PET Cyclotron Market by Application
- 5.1 Radiochemistry PET Cyclotron Application Introduction
- 5.1.1 Pharmaceutical Industry
- 5.1.2 Hospital
- 5.1.3 Research & Academics
- 5.2 Global Radiochemistry PET Cyclotron Sales Volume by Application
- 5.2.1 Global Radiochemistry PET Cyclotron Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radiochemistry PET Cyclotron Sales Volume by Application (2021-2032)
- 5.2.3 Global Radiochemistry PET Cyclotron Sales Volume Share by Application (2021-2032)
- 5.3 Global Radiochemistry PET Cyclotron Sales Value by Application
- 5.3.1 Global Radiochemistry PET Cyclotron Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radiochemistry PET Cyclotron Sales Value by Application (2021-2032)
- 5.3.3 Global Radiochemistry PET Cyclotron Sales Value Share by Application (2021-2032)
6 Radiochemistry PET Cyclotron Regional Sales and Value Analysis
- 6.1 Global Radiochemistry PET Cyclotron Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radiochemistry PET Cyclotron Sales by Region (2021-2032)
- 6.2.1 Global Radiochemistry PET Cyclotron Sales by Region: 2021-2026
- 6.2.2 Global Radiochemistry PET Cyclotron Sales by Region (2027-2032)
- 6.3 Global Radiochemistry PET Cyclotron Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Radiochemistry PET Cyclotron Sales Value by Region (2021-2032)
- 6.4.1 Global Radiochemistry PET Cyclotron Sales Value by Region: 2021-2026
- 6.4.2 Global Radiochemistry PET Cyclotron Sales Value by Region (2027-2032)
- 6.5 Global Radiochemistry PET Cyclotron Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 6.6.2 North America Radiochemistry PET Cyclotron Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 6.7.2 Europe Radiochemistry PET Cyclotron Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Radiochemistry PET Cyclotron Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 6.9.2 South America Radiochemistry PET Cyclotron Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Radiochemistry PET Cyclotron Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Radiochemistry PET Cyclotron Sales Value Share by Country, 2025 VS 2032
7 Radiochemistry PET Cyclotron Country-level Sales and Value Analysis
- 7.1 Global Radiochemistry PET Cyclotron Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Radiochemistry PET Cyclotron Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Radiochemistry PET Cyclotron Sales by Country (2021-2032)
- 7.3.1 Global Radiochemistry PET Cyclotron Sales by Country (2021-2026)
- 7.3.2 Global Radiochemistry PET Cyclotron Sales by Country (2027-2032)
- 7.4 Global Radiochemistry PET Cyclotron Sales Value by Country (2021-2032)
- 7.4.1 Global Radiochemistry PET Cyclotron Sales Value by Country (2021-2026)
- 7.4.2 Global Radiochemistry PET Cyclotron Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.9.2 France Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.16.2 China Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.19.2 India Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Radiochemistry PET Cyclotron Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Radiochemistry PET Cyclotron Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Radiochemistry PET Cyclotron Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 IBA Radiopharma Solutions
- 8.1.1 IBA Radiopharma Solutions Company Information
- 8.1.2 IBA Radiopharma Solutions Business Overview
- 8.1.3 IBA Radiopharma Solutions Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.1.4 IBA Radiopharma Solutions Radiochemistry PET Cyclotron Product Portfolio
- 8.1.5 IBA Radiopharma Solutions Recent Developments
- 8.2 Siemens Healthineers
- 8.2.1 Siemens Healthineers Company Information
- 8.2.2 Siemens Healthineers Business Overview
- 8.2.3 Siemens Healthineers Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Siemens Healthineers Radiochemistry PET Cyclotron Product Portfolio
- 8.2.5 Siemens Healthineers Recent Developments
- 8.3 GE Healthcare
- 8.3.1 GE Healthcare Company Information
- 8.3.2 GE Healthcare Business Overview
- 8.3.3 GE Healthcare Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.3.4 GE Healthcare Radiochemistry PET Cyclotron Product Portfolio
- 8.3.5 GE Healthcare Recent Developments
- 8.4 Advanced Cyclotron Systems (ACSI)
- 8.4.1 Advanced Cyclotron Systems (ACSI) Company Information
- 8.4.2 Advanced Cyclotron Systems (ACSI) Business Overview
- 8.4.3 Advanced Cyclotron Systems (ACSI) Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Advanced Cyclotron Systems (ACSI) Radiochemistry PET Cyclotron Product Portfolio
- 8.4.5 Advanced Cyclotron Systems (ACSI) Recent Developments
- 8.5 Sumitomo Heavy Industries
- 8.5.1 Sumitomo Heavy Industries Company Information
- 8.5.2 Sumitomo Heavy Industries Business Overview
- 8.5.3 Sumitomo Heavy Industries Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Sumitomo Heavy Industries Radiochemistry PET Cyclotron Product Portfolio
- 8.5.5 Sumitomo Heavy Industries Recent Developments
- 8.6 Best Cyclotron Systems
- 8.6.1 Best Cyclotron Systems Company Information
- 8.6.2 Best Cyclotron Systems Business Overview
- 8.6.3 Best Cyclotron Systems Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Best Cyclotron Systems Radiochemistry PET Cyclotron Product Portfolio
- 8.6.5 Best Cyclotron Systems Recent Developments
- 8.7 Ionetix Corporation
- 8.7.1 Ionetix Corporation Company Information
- 8.7.2 Ionetix Corporation Business Overview
- 8.7.3 Ionetix Corporation Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Ionetix Corporation Radiochemistry PET Cyclotron Product Portfolio
- 8.7.5 Ionetix Corporation Recent Developments
- 8.8 isoSolution
- 8.8.1 isoSolution Company Information
- 8.8.2 isoSolution Business Overview
- 8.8.3 isoSolution Radiochemistry PET Cyclotron Sales, Value and Gross Margin (2021-2026)
- 8.8.4 isoSolution Radiochemistry PET Cyclotron Product Portfolio
- 8.8.5 isoSolution Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Radiochemistry PET Cyclotron Value Chain Analysis
- 9.1.1 Radiochemistry PET Cyclotron Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radiochemistry PET Cyclotron Sales Mode & Process
- 9.2 Radiochemistry PET Cyclotron Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radiochemistry PET Cyclotron Distributors
- 9.2.3 Radiochemistry PET Cyclotron Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst